1. Biochemistry and Chemical Biology
  2. Cell Biology

The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ

  1. Masashi Watanabe
  2. Hidehisa Takahashi
  3. Yasushi Saeki
  4. Takashi Ozaki
  5. Shihori Itoh
  6. Masanobu Suzuki
  7. Wataru Mizushima
  8. Keiji Tanaka
  9. Shigetsugu Hatakeyama  Is a corresponding author
  1. Hokkaido University Graduate School of Medicine, Japan
  2. Tokyo Metropolitan Institute of Medical Science, Japan
https://doi.org/10.7554/eLife.05615
Share this article
Cite this article
  1. Masashi Watanabe
  2. Hidehisa Takahashi
  3. Yasushi Saeki
  4. Takashi Ozaki
  5. Shihori Itoh
  6. Masanobu Suzuki
  7. Wataru Mizushima
  8. Keiji Tanaka
  9. Shigetsugu Hatakeyama
(2015)
The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ
eLife 4:e05615.
https://doi.org/10.7554/eLife.05615
  2. Download BibTeX
  3. Download .RIS

Abstract

Adipocyte differentiation is a strictly controlled process regulated by a series of transcriptional activators. Adipogenic signals activate early adipogenic activators and facilitate the transient formation of early enhanceosomes at target genes. These enhancer regions are subsequently inherited by late enhanceosomes. PPARγ is one of the late adipogenic activators and is known as a master regulator of adipogenesis. However, the factors that regulate PPARγ expression remain to be elucidated. Here, we show that a novel ubiquitin E3 ligase, tripartite motif protein 23 (TRIM23), stabilizes PPARγ protein and mediates atypical polyubiquitin conjugation. TRIM23 knockdown caused a marked decrease in PPARγ protein abundance during preadipocyte differentiation, resulting in a severe defect in late adipogenic differentiation, whereas it did not affect the formation of early enhanceosomes. Our results suggest that TRIM23 plays a critical role in the switching from early to late adipogenic enhanceosomes by stabilizing PPARγ protein possibly via atypical polyubiquitin conjugation.

Article and author information

Author details

  1. Masashi Watanabe

    Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  2. Hidehisa Takahashi

    Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  3. Yasushi Saeki

    Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  4. Takashi Ozaki

    Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  5. Shihori Itoh

    Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  6. Masanobu Suzuki

    Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  7. Wataru Mizushima

    Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  8. Keiji Tanaka

    Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  9. Shigetsugu Hatakeyama

    Department of Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan
    For correspondence
    hatas@med.hokudai.ac.jp
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: Animal experimentation: All animal protocols were reviewed and approved by the Animal Welfare Committee of Hokkaido University. The work presented in this study is covered by the Animal Protocol Numbers APN-10-0077 and APN13-0040. All researchers, who performed procedures using live animal, were pre-approved by the Animal Welfare Committee of Hokkaido University, based on their completion of required animal use and care training, and acceptable previous experience in animal experiments.

Copyright

© 2015, Watanabe et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,381
    views
  • 808
    downloads
  • 66
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Masashi Watanabe
  2. Hidehisa Takahashi
  3. Yasushi Saeki
  4. Takashi Ozaki
  5. Shihori Itoh
  6. Masanobu Suzuki
  7. Wataru Mizushima
  8. Keiji Tanaka
  9. Shigetsugu Hatakeyama
(2015)
The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ
eLife 4:e05615.
https://doi.org/10.7554/eLife.05615

Share this article

https://doi.org/10.7554/eLife.05615

Categories and tags

Research organisms

Further reading

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics

    High-resolution deep mutational scanning of the melanocortin-4 receptor enables target characterization for drug discovery

    Conor J Howard, Nathan S Abell ... Nathan B Lubock
    Research Article

    Deep Mutational Scanning (DMS) is an emerging method to systematically test the functional consequences of thousands of sequence changes to a protein target in a single experiment. Because of its utility in interpreting both human variant effects and protein structure-function relationships, it holds substantial promise to improve drug discovery and clinical development. However, applications in this domain require improved experimental and analytical methods. To address this need, we report novel DMS methods to precisely and quantitatively interrogate disease-relevant mechanisms, protein-ligand interactions, and assess predicted response to drug treatment. Using these methods, we performed a DMS of the melanocortin-4 receptor (MC4R), a G-protein-coupled receptor (GPCR) implicated in obesity and an active target of drug development efforts. We assessed the effects of >6600 single amino acid substitutions on MC4R’s function across 18 distinct experimental conditions, resulting in >20 million unique measurements. From this, we identified variants that have unique effects on MC4R-mediated Gαs- and Gαq-signaling pathways, which could be used to design drugs that selectively bias MC4R’s activity. We also identified pathogenic variants that are likely amenable to a corrector therapy. Finally, we functionally characterized structural relationships that distinguish the binding of peptide versus small molecule ligands, which could guide compound optimization. Collectively, these results demonstrate that DMS is a powerful method to empower drug discovery and development.

    1. Biochemistry and Chemical Biology

    Coordinated regulation of chemotaxis and resistance to copper by CsoR in Pseudomonas putida

    Meina He, Yongxin Tao ... Wenli Chen
    Research Article

    Copper is an essential enzyme cofactor in bacteria, but excess copper is highly toxic. Bacteria can cope with copper stress by increasing copper resistance and initiating chemorepellent response. However, it remains unclear how bacteria coordinate chemotaxis and resistance to copper. By screening proteins that interacted with the chemotaxis kinase CheA, we identified a copper-binding repressor CsoR that interacted with CheA in Pseudomonas putida. CsoR interacted with the HPT (P1), Dimer (P3), and HATPase_c (P4) domains of CheA and inhibited CheA autophosphorylation, resulting in decreased chemotaxis. The copper-binding of CsoR weakened its interaction with CheA, which relieved the inhibition of chemotaxis by CsoR. In addition, CsoR bound to the promoter of copper-resistance genes to inhibit gene expression, and copper-binding released CsoR from the promoter, leading to increased gene expression and copper resistance. P. putida cells exhibited a chemorepellent response to copper in a CheA-dependent manner, and CsoR inhibited the chemorepellent response to copper. Besides, the CheA-CsoR interaction also existed in proteins from several other bacterial species. Our results revealed a mechanism by which bacteria coordinately regulated chemotaxis and resistance to copper by CsoR.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics

    Transcriptome-wide identification of 5-methylcytosine by deaminase and reader protein-assisted sequencing

    Jiale Zhou, Ding Zhao ... Zhanjun Li
    Research Article

    5-Methylcytosine (m5C) is one of the posttranscriptional modifications in mRNA and is involved in the pathogenesis of various diseases. However, the capacity of existing assays for accurately and comprehensively transcriptome-wide m5C mapping still needs improvement. Here, we develop a detection method named DRAM (deaminase and reader protein assisted RNA methylation analysis), in which deaminases (APOBEC1 and TadA-8e) are fused with m5C reader proteins (ALYREF and YBX1) to identify the m5C sites through deamination events neighboring the methylation sites. This antibody-free and bisulfite-free approach provides transcriptome-wide editing regions which are highly overlapped with the publicly available bisulfite-sequencing (BS-seq) datasets and allows for a more stable and comprehensive identification of the m5C loci. In addition, DRAM system even supports ultralow input RNA (10 ng). We anticipate that the DRAM system could pave the way for uncovering further biological functions of m5C modifications.